ArticleBMJ neurology open2025

Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.